Analysts' Actions: AMD, BAM, BX, GEN


Advanced Micro Devices ( AMD) was downgraded at Sterne Agee to Neutral from Buy. $8.50 price target. Slowing PC market limits upside, Sterne Agee said.

Brookfield Asset Management ( BAM) was downgraded at Credit Suisse to Neutral from Outperform. $38 price target. Limited excess potential return, Credit Suisse said.

The Blackstone Group ( BX) was upgraded at BMO to Outperform from Market Perform. $17 price target. Strong new asset growth, BMO said.

Nippon Telegraph and Telephone Corp. ( NTT) was upgraded to Buy at TheStreet Ratings.

Patrick Industries Inc. ( PATK) was upgraded to Buy at TheStreet Ratings.

Seattle Genetics ( SGEN) was initiated with a Buy rating at Think Equity. $30 price target. Adcetris opportunity in Hodgkin's lymphoma, Think Equity said.


Boeing ( BA) estimates were raised at UBS through 2012. Strong delivery mix, UBS said. Neutral rating and $72 price target.

CME Group ( CME) estimates were raised at Jefferies through 2013. Volume trends improved throughout quarter, Jefferies said. Buy rating.

EMC ( EMC) numbers were lowered at Oppenheimer. Shares are now seen reaching $32. Estimates were also lowered on channel checks in the financial vertical, Oppenheimer said. Outperform rating.

Lennar ( LEN) target was raised at Deutsche Bank. Shares are now seen reaching $30. Taking advantage of rising demand, Deutsche Bank said. Hold rating.

SXC Health Solutions Corp. ( SXCI) numbers were raised at Credit Suisse. Shares are now seen reaching $111. Estimates were also raised on focus on fiscal 2013 and 2014, Credit Suisse said. Outperform rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

7 Essential Rules for Investing in Tech Stocks

Wall Street Deflates in Pullback After Fed Excitement, No Records for Dow

Your Guide to Making a Lot of Money on the Driverless Car Boom